2008 Clinical Practice Guidelines - Canadian Diabetes Association

Nutr Metab. 1997;10:78-81.
56. Coscelli C, Lostia S, Lunetta M, et al. Safety, efficacy, acceptability
of a pre-filled insulin pen in diabetic patients over 60
years old. Diabetes Res Clin Pract. 1995;28:173-177.
57. Herz M, Sun B, Milicevic Z, et al. Comparative efficacy of
preprandial or postprandial Humalog Mix75/25 versus glyburide
in patients 60 to 80 years of age with type 2 diabetes
mellitus. Clin Ther. 2002;24:73-86.
58. Warren ML, Conway MJ, Klaff LJ, et al. Postprandial versus
preprandial dosing of biphasic insulin aspart in elderly type 2
diabetes patients. Diabetes Res Clin Pract. 2004;66:23-29.
59. Galic E,Vrtovec M, Bozikov V, et al.The impact of the timing
of Humalog Mix25 injections on blood glucose fluctuations in
the postprandial period in elderly patients with type 2 diabetes.
Med Sci Monit. 2005;11:P187-P192.
60. Meneilly GS. A comparison of insulin aspart and regular
insulin in elderly patients with type 2 diabetes. Diabetes Obes
Metab. 2007;9:754-755.
61. Hendra TJ, Taylor CD. A randomised trial of insulin on wellbeing
and carer strain in elderly type 2 diabetic subjects.
J Diabetes Complications. 2004;18:148-154.
62. Herman WH, Ilag LL, Johnson SL, et al.A clinical trial of continuous
subcutaneous insulin infusion versus multiple daily
injections in older adults with type 2 diabetes. Diabetes Care.
2005;28:1568-1573.
63. Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, et al.
Comparison of different insulin regimens in elderly patients
with NIDDM. Diabetes Care. 1996;19:1326-1332.
64. Janka HU, Plewe G, Busch K. Combination of oral antidiabetic
agents with basal insulin versus premixed insulin alone in
randomized elderly patients with type 2 diabetes mellitus. J Am
Geriatr Soc. 2007;55:182-188.
65. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based
antihypertensive treatment on cardiovascular disease risk in
older diabetic patients with isolated systolic hypertension.
Systolic Hypertension in the Elderly Program Cooperative
Research Group. JAMA. 1996;276:1886-1892.
66. Wang JG, Staessen JA, Gong L, et al. Chinese trial on isolated
systolic hypertension in the elderly. Systolic Hypertension in
China (Syst-China) Collaborative Group. Arch Intern Med.
2000;160:211-220.
67. Tuomilehto J, Rastenyte D, Birkenhäger WH, et al. Effects of
calcium-channel blockade in older patients with diabetes and
systolic hypertension. Systolic Hypertension in Europe Trial
Investigators. N Engl J Med. 1999;340:677-684.
68. Lindholm LH, Hansson L, Ekbom T, et al. Comparison of antihypertensive
treatments in preventing cardiovascular events in
elderly diabetic patients: results from the Swedish Trial in Old
Patients with Hypertension-2. STOP Hypertension-2 Study
Group. J Hypertens. 2000;18:1671-1675.
69. Voyaki SM, Staessen JA,Thijs L, et al; Systolic Hypertension in
Europe (Syst-Eur) Trial Investigators. Follow-up of renal function
in treated and untreated older patients with isolated systolic
hypertension. J Hypertens. 2001;19:511-519.
70. Barzilay JI, Davis BR, Bettencourt J, et al; ALLHAT
Collaborative Research Group. Cardiovascular outcomes using
doxazosin vs. chlorthalidone for the treatment of hypertension
in older adults with and without glucose disorders: a report
from the ALLHAT study. J Clin Hypertens (Greenwich). 2004;
6:116-125.
71. Rahman M, Pressel S, Davis BR, et al. Renal outcomes in highrisk
hypertensive patients treated with an angiotensin-converting
enzyme inhibitor or a calcium channel blocker vs a
diuretic: a report from the Antihypertensive and Lipid-
Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Arch Intern Med. 2005;165:936-946.
72. Whelton PK, Barzilay J, Cushman WC, et al; ALLHAT
Collaborative Research Group. Clinical outcomes in antihypertensive
treatment of type 2 diabetes, impaired fasting glucose
concentration, and normoglycemia:Antihypertensive and
Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALL-
HAT). Arch Intern Med. 2005;165:1401-1409.
73. Kjeldsen SE, Dahlöf B, Devereux RB, et al; LIFE (Losartan
Intervention for Endpoint Reduction) Study Group. Effects of
losartan on cardiovascular morbidity and mortality in patients
with isolated systolic hypertension and left ventricular hypertrophy:
a Losartan Intervention for Endpoint Reduction (LIFE)
substudy. JAMA. 2002;288:1491-1498.
74. Dahlöf B, Sever PS, Poulter NR, et al; ASCOT Investigators.
Prevention of cardiovascular events with an antihypertensive
regimen of amlodipine adding perindopril as required versus
atenolol adding bendroflumethiazide as required, in the Anglo-
Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering
Arm (ASCOT-BPLA): a multicentre randomised controlled
trial. Lancet. 2005;366:895-906.
75. Ferrari R; Perindopril and Remodeling in Elderly with Acute
Myocardial Infarction Investigators. Effects of angiotensin-converting
enzyme inhibition with perindopril on left ventricular
remodeling and clinical outcome: results of the randomized
Perindopril and Remodeling in Elderly with Acute Myocardial
Infarction (PREAMI) Study. Arch Intern Med. 2006;166:659-666.
76. Heart Outcomes Prevention Evaluation Study Investigators.
Effects of ramipril on cardiovascular and microvascular outcomes
in people with diabetes mellitus: results of the HOPE
study and MICRO-HOPE substudy. Lancet. 2000;355:253-259.
77. Fox KM; EURopean trial On reduction of cardiac events with
Perindopril in stable coronary Artery disease Investigators.
Efficacy of perindopril in reduction of cardiovascular events
among patients with stable coronary artery disease: randomised,
double-blind, placebo-controlled, multicentre trial
(the EUROPA study). Lancet. 2003;362:782-788.
78. McAlister FA, Campbell NR, Duong-Hua M, et al.
Antihypertensive medication prescribing in 27,822 elderly
Canadians with diabetes over the past decade. Diabetes Care.
2006;29:836-841.
79. Baigent C, Keech A, Kearney PM, et al; Cholesterol Treatment
Trialists’ (CTT) Collaborators. Efficacy and safety of cholesterol-lowering
treatment: prospective meta-analysis of data
S185
DIABETES IN SPECIAL POPULATIONS